Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 25 of 86 entries
View as:

Study of the Efficacy and Safety of BCD-089 in Combination With Methotrexate in Patients With Active Rheumatoid Arthritis

Phase: N/A Priority: Normal
NCT ID: NCT04227366 Org: User:
Start: 11/19/19 End: 03/01/22 Due: 03/01/23

Comparative Clinical Trial of Efficacy and Safety of BCD-057 and Humira® in Patients With Moderate to Severe Plaque Psoriasis

Phase: N/A Priority: Normal
NCT ID: NCT02762955 Org: User:
Start: 12/31/16 End: 10/15/18 Due: 10/15/19

Phase 1 Study of BCD-245 in Subjects With Neuroblastoma

Phase: N/A Priority: Normal
NCT ID: NCT05782959 Org: User:
Start: 11/29/21 End: 06/30/23 Due: 06/30/24

A Multicenter Open-Label Single-Arm Multi-Cohort Phase I Study of BCD-100 in Patients With Advanced Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT03050047 Org: User:
Start: 08/30/16 End: 11/30/18 Due: 11/30/19

Efficacy and Safety of Divozilimab in Patients With Neuromyelitis Optica Spectrum Disorders (AQUARELLE)

Phase: N/A Priority: Normal
NCT ID: NCT05730699 Org: User:
Start: 12/12/22 End: 09/30/26 Due: 09/30/27

Comparative Clinical Study of Pharmacokinetics, Tolerance and Safety of BCD-057 and Humira in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02395055 Org: User:
Start: 06/30/15 End: 10/31/15 Due: 10/31/16

Clinical Trial to Evaluate Efficacy and Safety of Multiple Subcutaneous Injections of Various Doses of BCD-085 in Patients With Active Ankylosing Spondylitis

Phase: N/A Priority: Normal
NCT ID: NCT02763111 Org: User:
Start: 09/30/16 End: 06/30/17 Due: 06/30/18

A Study to Assess the PK, PD, Safety and Immunogenicity of Single IV Infusion of BCD-264 and Darzalex in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT05974969 Org: User:
Start: 05/17/23 End: 08/15/23 Due: 08/15/24

Pharmacokinetics and Pharmacodynamics Study of BCD-066 Compared to Aranesp® in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02506881 Org: User:
Start: 03/31/13 End: 07/31/14 Due: 07/31/15

Clinical Study of Efficacy and Safety of BCD-085 (Monoclonal Anti-IL-17 Antibody) in Psoriatic Arthritis

Phase: N/A Priority: Normal
NCT ID: NCT03598751 Org: User:
Start: 07/25/18 End: 11/30/22 Due: 11/30/23

A Clinical Trial of the Efficacy and Safety of Levilimab (BCD-089) in Patients With Severe COVID-19

Phase: N/A Priority: Normal
NCT ID: NCT04397562 Org: User:
Start: 04/29/20 End: 08/03/20 Due: 08/03/21

Comparative Clinical Trial of Efficacy and Safety of BCD-055 and Remicade® in Combination With Methotrexate in Patients With Active Rheumatoid Arthritis

Phase: N/A Priority: Normal
NCT ID: NCT02762838 Org: User:
Start: 01/31/16 End: 07/31/18 Due: 07/31/19

An Open-label Randomized Multicenter Phase III Clinical Study Comparing Safety and Efficacy of Algeron (Cepeginterferon Alfa-2b) and and PegIntron (Peginterferon Alfa-2b) in Combination With Ribavirin as Combined Treatment of Chronic Hepatitis C in Human Immunodeficiency Virus-1 Infected Patients

Phase: N/A Priority: Normal
NCT ID: NCT02103439 Org: User:
Start: 06/06/13 End: 08/26/15 Due: 08/26/16

Comparative Clinical Trial to Evaluate Efficacy, Safety and Tolerance of BCD-054 and Avonex® for Treatment of Patients With Remitting-relapsing Multiple Sclerosis

Phase: N/A Priority: Normal
NCT ID: NCT02744222 Org: User:
Start: 08/10/17 End: 07/06/20 Due: 07/06/21

Study of the Pharmacodynamics, Pharmacokinetics, Safety, and Immunogenicity of Single Escalating Doses of BCD-180 in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT05407779 Org: User:
Start: 01/22/21 End: 09/30/23 Due: 09/30/24

A Double-Blind, Comparative, Randomized Clinical Study of the Pharmacokinetics, Safety, and Immunogenicity of a Single Intravenous Infusion of BCD-178 or Perjeta® in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT05738993 Org: User:
Start: 08/08/22 End: 01/31/24 Due: 01/31/25

An Open-label Comparative Efficacy and Safety Study of Algeron (Cepeginterferon Alfa-2b) in Treatment-naive Patients With Chronic Hepatitis C

Phase: N/A Priority: Normal
NCT ID: NCT01889433 Org: User:
Start: 07/10/13 End: 12/02/15 Due: 12/02/16

Clinical Trial of BCD-148 and Soliris® for the Treatment of Patients With Paroxysmal Nocturnal Hemoglobinuria

Phase: N/A Priority: Normal
NCT ID: NCT04060264 Org: User:
Start: 04/04/19 End: 12/30/20 Due: 12/30/21

Clinical Trial to Evaluate Efficacy and Safety of Acellbia® (JSC "BIOCAD") With Methotrexate in First Line Biological Therapy of Patients With Active Rheumatoid Arthritis

Phase: N/A Priority: Normal
NCT ID: NCT02744196 Org: User:
Start: 01/31/15 End: 08/31/17 Due: 08/31/18

Comparative Evaluation of Pharmacokinetics and Safety of BCD-055 and Remicade in Patients With Ankylosing Spondylitis

Phase: N/A Priority: Normal
NCT ID: NCT02359903 Org: User:
Start: 02/28/15 End: 11/30/15 Due: 11/30/16

Clinical Trial to Evaluate Pharmacokinetics, Pharmacodynamics and Safety of Leucostim® Compared to Neupogen®

Phase: N/A Priority: Normal
NCT ID: NCT02762799 Org: User:
Start: 07/18/16 End: 11/11/16 Due: 11/11/17

Dose-finding Study of Empegfilgrastim for Neutropenia Prophylaxis in Patients With Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01569087 Org: User:
Start: 05/31/12 End: 02/28/13 Due: 02/28/14

A Study of the Efficacy and Safety of Monotherapy With BCD-264 and Darzalex in Subjects With Relapsed and Refractory Multiple Myeloma

Phase: N/A Priority: Normal
NCT ID: NCT06296121 Org: User:
Start: 12/21/23 End: 07/31/26 Due: 07/31/27

A Safety and Efficacy Study of BCD-022 With Paclitaxel Compared to Herceptin With Paclitaxel in HER2+ Metastatic Breast Cancer Patients

Phase: N/A Priority: Normal
NCT ID: NCT01764022 Org: User:
Start: 10/31/12 End: 12/31/17 Due: 12/31/18

A Safety and Efficacy Study of BCD-021 With Paclitaxel and Carboplatin Compared to Avastin With Paclitaxel and Carboplatin in Non-Small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01763645 Org: User:
Start: 10/31/12 End: 11/30/14 Due: 11/30/15